Skip to main content
. 2019 Jun 10;39(6):BSR20182284. doi: 10.1042/BSR20182284

Table 3.

Subgroup analyses

Variables and cutoff Number of studies HR (95% CI) for subgroup I2 P for subgroup effect P for subgroup difference
Sample sizes
  <3000 3 1.12 [0.93, 1.35] 79% 0.23
  ≥3000 3 1.21 [1.13, 1.30] 0% <0.001 0.46
Mean ages (years)
  <65 3 1.09 [0.94, 1.27] 61% 0.24
  ≥65 3 1.24 [1.16, 1.32] 0% <0.001 0.12
Male (%)
  <40 2 1.22 [1.12, 1.33] 0% <0.001
  ≥40 4 1.14 [1.01, 1.29] 68% 0.04 0.36
Adiponectin measurements
  ELISA 4 1.13 [1.01, 1.27] 64% 0.03
  Others 2 1.25 [1.14, 1.37] 0% <0.001 0.20
AF confirmation
  Include AF hospitalization 5 1.22 [1.16, 1.29] 0% <0.001
  Not include AF hospitalization 1 0.95 [0.82, 1.11] 0.51 0.002
Follow-up duration (years)
  <10 1 0.95 [0.82, 1.11] 0.51
  ≥10 5 1.22 [1.16, 1.29] 0% <0.001 0.002
AF incidence (%)
  <15 3 1.09 [0.94, 1.27] 61% 0.24
  ≥15 3 1.24 [1.16, 1.32] 0% <0.001 0.12
Quality scores
  =8 2 1.18 [1.06, 1.31] 0% 0.003
  =9 4 1.16 [1.02, 1.31] 71% 0.02 0.83